How [...] turns Process Insights into measurable value with Celonis
Use Cases and Deployment Scope
At [...], we are on a mission to cut cycle times on our clinical research projects, enabling us to move from lab to first human dose (FHD) and from FHD to regulatory approval at unprecented speed - all in order to let us reach patients faster, and support with their long-term health needs.
In order to accelerate, we are working closely with Celonis to create digital twins of our R&D processes. This is already allowing us to see process variations and whitespace, and giving us an evidence-based foundation for process improvement initiatives, and investment in new digital tooling.
In short: Celonis allows us to move from "we think this is how the process works" to "here's how it actually looks, where it deviates from the written process, what it costs, and what to fix first".
Pros
- Process Intelligence
- Automation
- Root Cause Analysis
Cons
- As Celonis engages with more customers in heavily regulated industries, it would be great to see some additional effort given to the model for Lifecycle Management of products which impact on regulated processes. At times, the platform's capabilities are evolving faster than we can validate them to our regulated processes, which limits how we are allowed to use Celonis. A more mature LCM model with differentiated environments would allow customers in non-regulated industries to operate on the "bleeding edge", while still allowing customers in regulated environments to operate against a roadmap with a more predictable cadence (i.e. major/minor releases).
Return on Investment
- Enabling us to get patients enrolled on clinical trials earlier by supporting faster activation of clinical sites.
- Enabling us to speed-up the creation of audit-ready documentation, by replacing cumbersome, Excel-based decision making with AI-driven insights informed on current trial design and historical trends.
- Supports an evaluation of process health across the R&D value chain, enabling us to identify further automation/process improvement initiatives.

